Current Studies

Our Current Clinical Research Studies

Screen Shot 2021-09-23 at 6.00.21 PM

Hyperuricemic subjects with Gout and Mild to moderate Chronic Kidney Disease

Patients with Diabetic Cardiomyopathy

Outpatients with Mild to Moderate Covid-19 Illness
Screen Shot 2021-09-23 at 6.36.13 PM
Screen Shot 2021-09-23 at 6.41.20 PM

Participants with Atherosclerotic Cardiovascular Disease who are not adequately Controlled Despite Maximally Tolerated Lipid-Modifying Therapies
Screen Shot 2021-07-07 at 12.35.33 PM
Close-up of a human cardiovascular system

Patients with Chronic Heart Failure with Reduced Ejection Fraction

Patients with Diabetic Cardiomyopathy
Close-up of a human cardiovascular system

Patients with Heart Failure with Preserved Ejection Fraction Acute decompensated Heart Failure who have been stabilized during hospitalization

Adaptive Platform treatment trial for Outpatients with Covid-19

A 2-Part, 2-Arm, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study on the Safety and Efficacy of Niclosamide in Patients with COVID-19 with Gastrointestinal Infection
Screen Shot 2022-07-20 at 8.32.50 PM

Rivus Pharmaceuticals, KBP Bioscience, AstraZeneca, Gilead Sciences.
Screen Shot 2022-07-20 at 8.32.50 PM

Rivus Pharmaceuticals

Exploratory Phase 2A, Double-Blind, Placebo-Controlled Study of Subjects with Obese Heart Failure with Preserved Ejection Fraction.

Screen Shot 2022-07-20 at 8.33.30 PM

KBP Biosciences

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study in Subjects with Uncontrolled Hypertension Who Have Moderate or Severe (Stage 3b/4) Chronic Kidney Disease.

Screen Shot 2022-07-20 at 8.41.48 PM

AstraZeneca AB

A Phase 2, Randomised, Double-Blind, Placebo in Adults with Moderate-to-Severe Uncontrolled Asthma

Screen Shot 2022-07-20 at 8.48.21 PM

Gilead Sciences

A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH)